Genetic results and laboratory results answer different questions.
Your DNA may suggest:
What biological susceptibilities you inherited.
A laboratory test may show:
What can be measured in your body right now.
Those are not the same thing.
A genetic variant related to:
does not automatically mean the associated condition or biochemical abnormality is currently present.
Likewise, an abnormal lab result can exist even when no strong genetic susceptibility appears in your DNA.
This distinction is central to useful genetic health interpretation.
A better model is:
Genetics = inherited susceptibility
Labs = current measurable state
Medical records = what has happened over time
Symptoms = what you are experiencing
AI = a tool for comparing those layers
Mutant Genomics is designed around that separation.
Mutant first converts compatible DNA data into:
Relevant genetic markers
↓
Genetic module patterns
↓
Converging patterns
↓
Ranked health hypotheses
↓
Supporting evidence + DNA coverage
Those hypotheses can then be compared with:
The goal is not to make the labs confirm the genetics.
It is to determine whether the genetics are actually relevant.
Your top 3 ranked health hypotheses are included in full with Mutant Free. No credit card required.
Your complete raw DNA stays in your browser. Mutant retains only the genetic markers needed for your analysis.
Genetic testing generally evaluates inherited DNA variation.
Laboratory testing measures current biological markers such as:
Genetics may help explain susceptibility.
Labs may help determine whether the associated biological pattern is currently present.
Usually not.
A genetic finding involving:
does not establish current deficiency.
Actual nutrient status depends on:
Yes.
A genetic susceptibility can be real while having little apparent current relevance.
For example:
MTHFR-related susceptibility
+
adequate folate
+
adequate B12
+
repeatedly normal homocysteine
may make a folate-centered explanation less compelling.
Yes.
Genetics does not need to explain every biological problem.
A person can develop:
without Mutant identifying a strong inherited susceptibility in the relevant pathway.
A common mistake in consumer genetics is treating DNA as though it were a blood test.
For example:
"My vitamin D genes are bad, so my vitamin D must be low."
or:
"My HFE result means I have iron overload."
or:
"My DIO2 variant means my T3 is low."
or:
"My MTHFR result means my homocysteine is high."
Those conclusions skip an important step.
The genetics may justify asking:
Should this biological area be investigated more closely?
The lab result may help answer:
Is there measurable evidence that the hypothesis matters right now?
Your inherited DNA does not meaningfully change because:
That stability makes genetics useful for identifying baseline susceptibility.
But it also means DNA cannot tell you exactly what your current physiology looks like today.
Laboratory results can change with:
That makes labs useful for understanding the current measurable state.
Suppose someone carries an HFE-related iron-overload susceptibility.
At age 25:
Later:
The genotype did not change.
Its current clinical relevance changed.
The opposite can also happen.
A genetic finding may appear interesting while current labs remain reassuring for many years.
A useful genetic result should usually sound like:
"Your genetics may increase susceptibility to this biological pattern."
not:
"Your DNA proves this pathway is currently failing."
Mutant therefore frames findings as ranked health hypotheses.
A hypothesis may involve:
The next step is to ask:
What real-world evidence supports or weakens it?
Some genetic hypotheses map naturally to laboratory measurements.
Others do not.
For example:
can be compared with:
can be compared with:
can be compared with:
can be compared with:
But not every genetic pattern has one definitive laboratory test.
Some genetic reports imply that every pathway can be measured directly.
That is rarely true.
For many systems:
For example, common genetics cannot directly measure:
This is why genetic interpretation should not pretend that every module has a single confirming test.
MTHFR is one of the most commonly overinterpreted genetic findings.
A common report may say:
MTHFR variant = impaired methylation
But the current biological picture depends on more than MTHFR.
Relevant context may include:
Suppose Mutant identifies:
Lower folate-dependent methionine-recycling reserve
but Health Context shows:
The better conclusion may be:
The genetic susceptibility exists, but it may not be particularly relevant to the current health question.
That is more useful than:
"You have an MTHFR problem."
HFE-related variants can be clinically important.
But genetics and current iron status remain separate questions.
A person may have:
HFE-related iron-overload susceptibility
without currently having:
iron overload.
Useful current evidence may include:
The genetics can increase the importance of monitoring or confirmation.
The laboratory results help determine whether iron accumulation is actually occurring.
Ferritin can rise for reasons unrelated to hereditary hemochromatosis.
Possible contributors include:
That is why:
HFE genetics + ferritin
may still be insufficient by themselves.
Transferrin saturation and broader clinical context can matter.
Mutant may identify genetic susceptibility involving:
These findings do not establish current thyroid dysfunction.
A common DIO2 variant may contribute to inherited context involving thyroid-hormone activation.
It cannot determine current:
A genetic finding such as:
Lower cellular T3-activation reserve
should therefore be compared with real-world thyroid context.
The opposite oversimplification is also possible.
A normal TSH can make common primary hypothyroidism less likely in many situations.
But thyroid interpretation may also depend on:
The correct question is not:
"Does the genetics override TSH?"
It is:
"Does the total thyroid evidence support the genetic hypothesis?"
Mutant may identify:
Autoimmune thyroid susceptibility
through genetic context involving:
That does not prove:
Relevant clinical evidence may include:
Genetic susceptibility may remain present even when antibodies are negative.
But the absence of clinical evidence can make the hypothesis less relevant to the current problem.
Lipoprotein(a) is strongly influenced by genetics.
A Mutant hypothesis may indicate:
Greater inherited susceptibility to elevated Lp(a).
But the most useful current-state question is still:
What is the person's measured Lp(a)?
Relevant Health Context may include:
This is an excellent example of:
Genetics identifying inherited risk
while:
the laboratory test measures the phenotype more directly.
Genetic models are not exhaustive.
If a person's measured Lp(a) is elevated, that result matters regardless of whether Mutant has complete genetic evidence explaining it.
Real-world biomarkers do not need permission from the genetics.
Mutant may identify selected inherited patterns involving genes such as:
depending on available evidence.
But a genetic hypothesis should be evaluated alongside:
A clinically important lipid phenotype can exist even when no currently modeled pathogenic variant is detected.
Likewise, a potentially important variant may deserve confirmation even before severe lipid abnormalities appear.
A relevant F5 finding may indicate inherited thrombophilia susceptibility.
That does not mean:
A blood clot is currently present.
The genetics identify a risk factor.
Health Context may include:
Potentially significant inherited findings may require clinical confirmation.
This is another example of why the correct lab must match the biological question.
Routine tests such as:
do not necessarily function as direct screening tests for every inherited thrombophilia.
The appropriate interpretation depends on the specific clinical question.
G6PD-related genetic findings may identify inherited susceptibility.
Current clinical evaluation may involve:
Genetics can provide inherited context.
The enzyme test helps evaluate current functional activity.
Certain testing situations may complicate interpretation, which is another reason clinical context matters.
Genes involved in:
may contribute modestly to vitamin D status or response.
They cannot determine current vitamin D level.
The relevant laboratory measurement is typically:
25-hydroxy vitamin D
when testing is clinically appropriate.
Someone with vitamin D-related genetic susceptibility may still have:
adequate vitamin D.
Someone with reassuring genetics may still develop:
vitamin D deficiency.
Common VDR variants are often overstated.
A VDR SNP does not generally establish:
The genetics may provide context.
The current biochemical state requires other evidence.
Genetic susceptibility may involve:
But current B12 status can depend on:
Useful testing may include, depending on the situation:
Genetics can provide context.
It cannot diagnose B12 deficiency.
No laboratory marker is perfect.
Interpretation can depend on:
The point is not:
Labs are always definitive.
The point is:
Labs and genetics provide different kinds of evidence.
A person can have strong genetic susceptibility to iron overload and still become iron deficient.
Likewise, a person with no obvious HFE-related susceptibility can develop iron overload from other causes.
DNA does not eliminate the need to assess actual iron status.
This is why genetic labels such as:
iron gene
are often too broad.
Mutant may identify susceptibility involving:
But there is no single routine lab test that definitively establishes every case of histamine intolerance.
Health Context may therefore rely more heavily on:
This demonstrates an important principle:
Not every genetic hypothesis maps neatly to one laboratory number.
AOC1-related genetics may contribute to inherited intestinal histamine-clearance susceptibility.
They cannot directly measure:
A person's genetics can remain unchanged while tolerance changes dramatically.
Mutant may identify:
Enteric motility & clearance susceptibility
But genetics cannot establish current transit speed.
Health Context may include:
A documented pelvic-floor disorder may explain constipation better than a genetic motility hypothesis.
Genetics may identify inherited susceptibility involving:
Current glucose physiology may be evaluated with measurements such as:
A genetic susceptibility does not automatically mean diabetes is present.
And diabetes can develop without Mutant identifying a strong genetic hypothesis.
This is where the distinction becomes especially important.
Mutant may identify patterns involving:
But routine blood testing does not directly tell you current brain:
This means:
Genetics cannot be "confirmed" with a simple neurotransmitter blood panel.
Interpretation may instead depend more heavily on:
A peripheral neurotransmitter measurement is not automatically equivalent to neurotransmitter signaling inside specific brain circuits.
That distinction matters when interpreting:
The brain is not a single bucket of neurotransmitters that can be inferred from one peripheral measurement.
This distinction becomes especially important for inherited health findings.
Someone may carry:
increased inherited risk
without currently having:
active disease.
For example:
may increase risk without a current clot.
may increase susceptibility without current iron overload.
may suggest inherited predisposition while actual Lp(a) measurement remains central.
may alter kidney-risk context without proving current kidney disease.
The reverse matters equally.
A person can have:
without Mutant identifying a strong corresponding genetic pattern.
Most common diseases arise from combinations of:
Genetics is one layer.
This sounds contradictory, but it is not.
Some inherited findings matter because they may affect:
For example, a potentially significant inherited result may still deserve:
even when current biomarkers are reassuring.
The correct interpretation is not always:
Normal labs = genetic finding irrelevant.
Sometimes it is:
Genetic susceptibility is important, but there is no current biochemical evidence of the associated phenotype.
Suppose someone has:
very low ferritin
but Mutant shows no strong modeled iron-related susceptibility.
The low ferritin still matters.
Possible causes may include:
Genetics is not required for a biochemical abnormality to be real.
A reassuring genetic model should not be translated into:
"You cannot have this problem."
Mutant evaluates selected genetic evidence.
It does not test every possible:
A lack of genetic support may reduce confidence in a genetic hypothesis.
It does not rule out the biological condition.
Genetics is not the only data source that can be overinterpreted.
One abnormal lab value may reflect:
That is why trends can matter.
For example:
Ferritin 300 once
is different from:
Ferritin repeatedly elevated over several years with high transferrin saturation.
Likewise:
TSH 4.8 once during illness
is different from:
repeated abnormal thyroid tests.
AI and clinicians can often reason more effectively when given:
A lab value without units may be ambiguous.
Instead of:
Vitamin D = 25
provide:
25-OH Vitamin D = 25 ng/mL, laboratory reference 30–100
when available.
Ideally include:
Another common mistake is treating every result inside the laboratory reference interval as:
perfect
or every result outside as:
disease.
Reference ranges are laboratory tools.
Clinical interpretation can depend on:
Mutant should not replace those distinctions with a universal "optimal range."
The purpose of Health Context is not to reinterpret every normal laboratory result as abnormal.
A normal result may provide meaningful evidence against a hypothesis.
That is important.
A good hypothesis should be able to lose.
Suppose Mutant identifies a thyroid-related susceptibility.
Repeatedly reassuring thyroid testing can matter.
Suppose Mutant identifies methionine-recycling susceptibility.
Repeatedly reassuring:
can matter.
Suppose Mutant identifies iron-overload susceptibility.
Normal:
can matter.
Do not discard normal data because it does not confirm the genetics.
A genetic finding may sound compelling until Health Context shows that the associated problem has already been investigated.
Examples may include:
These findings can:
Sometimes genetics may help explain a persistent laboratory pattern.
For example, inherited variation may contribute to differences in:
This is where genetics and labs can be particularly complementary.
UGT1A1-related genetics can influence bilirubin conjugation.
A compatible genetic pattern may help explain:
persistent mild unconjugated bilirubin elevation
in an appropriate clinical context.
But genetics should still be compared with:
A genetic explanation should not be used to ignore incompatible findings.
Selected inherited hemoglobin findings may help explain patterns involving:
But similar laboratory patterns can have different causes.
For example:
low MCV
can occur with:
Genetics can help differentiate possibilities.
It does not replace actual blood testing.
Suppose Mutant identifies a thalassemia-related inherited hypothesis.
A CBC showing a compatible persistent microcytic pattern may strengthen interest.
But iron studies remain important because:
thalassemia and iron deficiency can overlap.
This is exactly the kind of situation where multiple evidence layers matter.
Suppose Mutant identifies HFE-related susceptibility.
The user's main complaint is insomnia.
The HFE finding may be real.
It may also be unrelated to the sleep problem.
A genetic finding does not become the cause of every symptom merely because it is important.
The same principle applies to laboratory data.
A mild abnormality may be:
AI-assisted reasoning should not assume:
the most abnormal lab = the cause.
The question is:
Which evidence best fits the timing, phenotype, and biological mechanism?
Mutant does not simply attach a list of recommended labs to every SNP.
It uses health hypotheses as the bridge.
The conceptual model is:
hypothesis ├── interpretation ├── genetic_evidence ├── dna_coverage ├── health_context │ ├── relevant_labs │ ├── relevant_symptoms │ ├── relevant_history │ ├── medications_exposures │ ├── strengthens_hypothesis │ ├── weakens_hypothesis │ ├── alternative_explanations │ └── questions_to_explore └── sources
The key is that the laboratory data belongs inside a hypothesis-testing framework.
A weak approach is:
Order every test related to every genetic finding.
That creates:
A stronger approach asks:
Which information would actually distinguish among the leading hypotheses?
Suppose Mutant identifies higher-ranked hypotheses involving:
The next question is not:
Which genetic supplement protocol should I follow?
It may be:
Which existing labs and medical history support each explanation?
Relevant evidence might include:
The best explanation may not be the highest genetic hypothesis.
Mutant might identify:
Health Context may show:
Now the gut-motility genetics may remain interesting but no longer be the leading explanation.
Mutant may identify:
But Health Context may show:
or:
or:
The genetic histamine hypothesis should not override stronger clinical evidence.
Some hypotheses do not have a single direct laboratory marker.
That does not make them untestable.
They may still be evaluated using:
For example:
Stress & Autonomic Regulation
may require a different evidence framework from:
HFE-related iron overload.
Not every hub should look like a lab-report interpretation.
Consider:
Genetics
showing an iron-overload susceptibility.
Labs
showing repeatedly elevated transferrin saturation.
Medical records
showing a family history of iron overload.
That convergence is stronger than any one layer alone.
But consider the opposite:
Genetics
showing histamine susceptibility.
Labs and records
showing a confirmed conventional allergy explaining the episodes.
The genetics may become secondary.
The framework must support both outcomes.
This is where AI becomes particularly useful.
AI can help ask:
Does the laboratory history support this genetic hypothesis?
Which normal results weaken it?
Does the medical record contain a better explanation?
Did symptoms begin before or after medication changed?
Is this inherited finding clinically important even though current labs are normal?
Which hypothesis best explains the total evidence?
If AI receives:
Mutant says I have a thyroid hypothesis. Find evidence that proves it.
the reasoning starts biased.
A better instruction is:
Evaluate this hypothesis against my labs and medical records. Identify evidence that strengthens it, evidence that weakens it, alternative explanations, and important missing information. Do not assume the genetic hypothesis is correct.
That is the Health Context model.
Suppose Mutant identifies:
Histamine-clearance susceptibility
but:
The correct conclusion may be:
The genetic susceptibility exists, but it may not be particularly relevant to the current health question.
The same principle applies across every Mutant system.
A useful evidence hierarchy may look like:
Examples:
Examples:
Examples:
Examples:
Not every case fits this hierarchy perfectly.
But it prevents one common SNP from outweighing much stronger real-world evidence.
A common pattern in wellness genetics is:
"Your labs are normal, but your genes show a hidden problem."
Sometimes genetics can reveal meaningful inherited susceptibility before disease appears.
But that logic can also become impossible to disprove.
If:
and:
then the hypothesis can never lose.
That is not good reasoning.
For example:
Methylation susceptibility
plus:
normal folate + B12 + homocysteine
can make a current folate-cycle dysfunction hypothesis less compelling.
Similarly:
iron-overload susceptibility
plus:
normal iron markers
can indicate inherited risk without current evidence of overload.
The genetics remain real.
Their current relevance changes.
There are exceptions.
Certain inherited findings may be important because they influence:
That is why Mutant distinguishes:
common susceptibility patterns
from:
potentially significant inherited findings.
The latter may deserve confirmation even when current biomarkers are normal.
Potentially important findings identified through consumer DNA should not automatically be treated as confirmed medical results.
Depending on the finding, next steps may include:
This is especially important for findings related to:
A common variant such as one involving:
usually belongs in a susceptibility model.
It should not be treated as though it has the same meaning as a high-impact inherited pathogenic variant.
Mutant keeps those categories conceptually separate.
Mutant groups related evidence into genetic modules representing specific biological functions.
Examples may include:
A module asks:
What does this group of genetic evidence collectively suggest?
That is more useful than:
What does this one red SNP mean?
Several independent modules may support the same biological theme.
For example:
Folate-cycle susceptibility
+
B12-dependent recycling susceptibility
+
limited choline/betaine compensation
may provide stronger evidence than MTHFR alone.
Or:
enteric-motility susceptibility
+
autonomic context
+
thyroid-related susceptibility
may make a slow-motility hypothesis more interesting.
Then Health Context determines whether the pattern actually fits.
Suppose one module suggests reduced reserve.
Another indicates a strong alternative pathway.
That may make the final hypothesis weaker.
This is why:
more genetic data should not automatically produce more risk.
Additional evidence can reduce concern.
Suppose Mutant identifies a hypothesis using incomplete genetic evidence.
A strong lab pattern may still matter.
But the genetic hypothesis should reflect that:
coverage is incomplete.
Conversely, a lack of genetic support based on low coverage should not be interpreted as:
genetic reassurance.
This is especially important with:
because consumer arrays test selected markers rather than the whole genome.
If a relevant variant is unavailable:
Mutant treats it as missing data.
It does not assume:
or:
WGS generally provides broader coverage of Mutant's modeled markers.
That can mean:
But WGS does not make lab testing unnecessary.
A genome still cannot tell you the current value of:
Suppose broader sequencing becomes available.
The additional evidence may:
The purpose of WGS is not:
finding more things wrong.
It is:
improving evidence completeness.
Mutant supports compatible data from:
The same underlying Mutant analysis framework applies.
Your DNA source determines:
How much relevant genetic evidence is available.
Your plan determines:
How much of the resulting analysis you can access.
These are different things.
Mutant Health Context can help organize which real-world evidence is relevant to a health hypothesis.
For each hypothesis, useful context may include:
Which current biomarkers may inform the hypothesis?
Which findings would make the hypothesis more plausible?
Which findings would make it less plausible?
What other mechanisms could create the same lab or symptom pattern?
What information is still missing?
This is not the same as:
"Here is a list of tests everyone should order."
A genetic hypothesis becomes less useful if every lab can somehow be interpreted as confirming it.
For example:
High homocysteine = confirms MTHFR
and:
Normal homocysteine = MTHFR is still hidden
would make the hypothesis impossible to challenge.
Mutant's direction is different.
A normal result should be allowed to:
weaken the current relevance of the hypothesis.
The same standard applies in reverse.
An abnormal lab should prompt questions such as:
Health Context should not turn one abnormal lab into a genetic diagnosis.
Many medications can influence:
That means:
genetics + abnormal lab
may still be insufficient without medication context.
Examples may include:
Supplement use should therefore be included when comparing genetics and labs.
A lab drawn:
before treatment
may mean something different from:
the same lab after six months of supplementation.
Likewise:
symptoms starting before a lab abnormality
may affect causal interpretation.
Chronology matters.
Medical records can help answer:
This prevents AI or genetics from reconstructing history incorrectly.
Once Mutant structures the genetic layer, AI can help ask:
Which labs directly support this hypothesis?
Which labs argue against it?
Are the abnormal results persistent?
Do medical records contain another explanation?
Did medication change before symptoms began?
Which inherited finding may require confirmation?
What evidence is still missing?
A better prompt is:
Evaluate this Mutant genetic hypothesis against my laboratory results and medical history. Distinguish inherited susceptibility from current disease. Identify evidence that strengthens the hypothesis, evidence that weakens it, alternative explanations, and important missing information. Do not assume the genetic hypothesis is correct simply because it has genetic support.
That is much stronger than:
"Do these labs prove my genes are causing my symptoms?"
A useful summary might look like:
HFE-related iron-overload susceptibility.
Strong.
High for the modeled hypothesis.
The inherited susceptibility is meaningful and the laboratory pattern adds support, but confirmation and broader clinical interpretation are still appropriate.
That is better than:
"Your DNA says you have iron overload."
Lower folate-dependent methionine-recycling reserve.
Moderate.
The genetic susceptibility exists, but current biochemical evidence does not strongly support it as the cause of the fatigue.
That is exactly what Health Context should be able to conclude.
Low vitamin B12.
No strong modeled B12-related susceptibility.
The B12 deficiency can be explained by dietary exposure without requiring a genetic cause.
Genetics should not be forced into every explanation.
There is no single "gut health lab" that confirms all gut genetic findings.
Genetics may involve:
Relevant current context may include:
Genetics may involve:
Relevant evidence may include:
Potentially important inherited findings may require clinical confirmation.
Genetics may provide susceptibility.
Labs measure current thyroid-related physiology.
Genetics can provide susceptibility.
There is no single definitive routine blood test for every histamine-intolerance hypothesis.
Genetics may suggest lower metabolic reserve.
Relevant context may include:
Genetic patterns may provide context around cellular-energy biology.
Routine labs do not directly measure mitochondrial function in every tissue.
Genetics may influence:
Actual status may require:
Genetics may contribute susceptibility.
Current levels require appropriate laboratory testing.
Genetics may provide context around:
There is no universal laboratory panel that measures a person's global "detox capacity."
Mutant evaluates:
These are especially important examples of why:
genetic pattern ≠ directly measurable blood neurotransmitter state.
Health Context may rely more on:
rather than a single lab.
Most people carry many common variants.
If each one triggers a long laboratory panel, the result can be:
Testing should ideally answer a specific question.
The sequence should be closer to:
Genetic hypothesis
↓
Is it relevant to the current health problem?
↓
Would a particular lab meaningfully strengthen or weaken it?
not:
SNP detected → order everything related to the gene.
The reverse mistake is equally important.
If a current laboratory result shows a significant abnormality:
the absence of a strong Mutant genetic finding does not erase it.
Genetic coverage may be incomplete.
The condition may be acquired.
Environmental or medication factors may dominate.
Clinical evidence should be taken seriously on its own terms.
Genetic explanations can be attractive because they feel foundational.
But many lab abnormalities have common acquired causes.
For example:
may involve:
may involve:
may involve:
Genetics can contribute.
It should not automatically be the first or only explanation.
Some inherited risks do not require a current abnormal blood test to remain meaningful.
Examples may include:
The appropriate question is:
Does this genetic finding matter for current disease, future risk, family implications, or confirmation?
Different findings require different interpretation.
Suppose Mutant finds a meaningful genetic susceptibility.
But Health Context shows:
A good conclusion can be:
The inherited susceptibility is present, but there is no strong current evidence that the associated phenotype is active.
That can be a valuable result.
Suppose Mutant genetics are unremarkable.
But a laboratory test shows:
significant iron deficiency
or:
clear hypothyroidism
or:
markedly elevated Lp(a).
The lab may deserve far more attention than the genetic model.
Mutant should not compete with stronger evidence.
AI can combine:
more efficiently than traditional static reports.
But if the data layers are not clearly separated, AI may make errors such as:
Genetic susceptibility = current disease
or:
One abnormal lab = genetic cause
A structured Health Context helps prevent that.
Mutant focuses on:
AI can then help compare those findings with:
The jobs are related but different.
When evaluating any Mutant result, ask:
Inherited susceptibility
Current measurable state
Longitudinal history
Symptoms and real-world pattern
Alternative mechanisms
That is the core Health Context workflow.
DNA and health records are both highly sensitive.
Before sharing them with any AI or health platform, understand:
Mutant does not require your complete raw DNA file to be uploaded and stored.
When you add compatible DNA data:
Your complete raw DNA is not uploaded or stored by Mutant.
Medical documents may contain:
If those details are not needed for your AI use case, consider removing them before manually sharing the records.
Keep the information that actually matters to the analysis:
Mutant supports compatible data from:
You do not need a new DNA test to begin if you already have compatible consumer genetic data.
Mutant Free includes:
Your top 3 hypotheses can come from any biological system or hub.
No credit card required.
Mutant Full unlocks all remaining findings available from your analysis.
Included:
You can start free and upgrade later.
Mutant Free does not use a smaller analysis model.
The same underlying Mutant analysis generates your findings.
Your top 3 ranked health hypotheses are completely unlocked.
All remaining ranked hypotheses are also unlocked.
A free hypothesis is not a teaser.
You can inspect:
in full.
They answer different questions.
Genetics measures inherited DNA.
Blood tests measure current biological markers.
Neither universally replaces the other.
Usually not.
DNA cannot directly determine current:
Sometimes labs can provide supporting evidence for the phenotype associated with a genetic finding.
But the correct lab depends on the genetic hypothesis.
It may make the genetic hypothesis less relevant to your current health question.
But some inherited findings remain important for:
even when current labs are normal.
Yes.
Most nutrient deficiencies can occur for non-genetic reasons.
Yes.
Acquired health conditions do not require a detectable genetic susceptibility.
No.
MTHFR genetics cannot measure current folate.
No.
Homocysteine must be measured directly if testing is appropriate.
The genotype still exists.
But normal homocysteine and adequate folate/B12 may weaken the argument that folate-dependent methionine recycling is currently a major problem.
No.
DIO2 genetics cannot determine current T3.
No.
Current thyroid function requires appropriate clinical and laboratory evaluation.
No.
HFE genetics can identify susceptibility.
Current iron status depends on tests such as:
and broader clinical context.
Not necessarily a question that can be answered from ferritin alone.
Interpretation may also involve:
A genetic finding can exist without current overload.
No.
Genetics can suggest inherited susceptibility.
Measured Lp(a) provides direct current phenotype information.
Genetics can identify some inherited lipid-risk patterns.
Actual cholesterol and lipid levels require measurement.
Routine clotting tests are not equivalent to specific Factor V Leiden testing.
A potentially relevant genetic result may require confirmation.
Genetics can identify relevant inherited variants.
Clinical evaluation may include enzyme testing and medical history.
No.
Current vitamin D status is measured with appropriate laboratory testing, typically 25-OH vitamin D.
No.
Common VDR variants do not determine a supplement dose.
No.
Current B12 status depends on:
No.
DAO-related genetics cannot measure current histamine or intestinal DAO activity.
There is no single universally accepted test that definitively establishes every case of histamine intolerance.
Clinical context matters.
No.
Peripheral dopamine measurement is not a direct measure of brain catecholamine signaling.
No.
Common genetic patterns cannot measure current brain GABA.
No.
Stress-related genetics may provide susceptibility context but cannot measure current cortisol.
No.
Genetics may provide context around mineral handling.
Current magnesium status depends on actual physiology and testing.
No.
A genetic finding cannot replace current nutritional or laboratory assessment.
No.
Testing should ideally answer a relevant clinical question rather than follow every common SNP.
Not automatically.
The importance depends on whether the finding represents:
No.
Abnormal current-state evidence may matter even when genetics do not explain it.
Yes.
AI can help compare structured genetic hypotheses with lab trends and other Health Context.
Explore How to Combine DNA, Labs & Medical Records With AI →
AI can reason across both types of information.
It works best when genetic data has first been structured into meaningful findings rather than asking AI to infer everything from a raw genome file.
It can help compare evidence quality and identify:
Important clinical conclusions still require appropriate professional evaluation.
Not automatically.
Agreement can strengthen a hypothesis.
Diagnosis may still require:
No.
Mutant provides genetic health hypotheses and Health Context for evaluating them.
It does not convert a lab value into a definitive diagnosis.
No.
You can generate a Mutant genetic analysis without lab data.
Labs are optional Health Context.
No.
The questionnaire is optional.
Health Context may also come from:
Yes.
The genetic hypothesis remains available as context, while new health information can change how relevant it appears.
Yes.
New:
may weaken or replace a previous explanation.
That is expected.
Yes.
The genetics may remain unchanged while new:
make the hypothesis more relevant.
No.
Your complete raw DNA is read locally in your browser.
Only genetic markers required for Mutant's current models are sent and retained.
Yes.
Compatible 23andMe raw DNA can provide useful coverage.
WGS generally provides broader genetic coverage.
It does not replace current laboratory testing.
No.
If you already have compatible 23andMe or AncestryDNA data, you can start with it.
Mutant Free includes your top 3 ranked health hypotheses across your entire analysis in full.
No.
Free controls breadth, not depth.
Your included hypotheses are fully accessible.
Mutant Full is $49/year.
It unlocks all remaining ranked hypotheses available from your analysis.
The most important distinction is simple:
Genetic result ≠ current biochemical result
Your DNA can identify:
Laboratory testing can provide:
Medical records add:
what happened over time.
Symptoms add:
what you are actually experiencing.
AI can help determine:
how well those layers agree.
Mutant organizes the genetics through:
Relevant genetic markers
↓
Genetic module patterns
↓
Converging patterns
↓
Ranked health hypotheses
↓
Supporting evidence + DNA coverage
↓
Health Context
The goal is not:
Find labs that confirm every genetic result.
It is:
What current evidence supports this hypothesis?
What weakens it?
Could another explanation fit better?
Is this inherited finding important even if current labs are normal?
Is the lab abnormal even though genetics do not explain it?
A good genetic hypothesis should be able to become stronger.
It should also be able to lose.
Mutant interprets the genetics.
AI helps connect it to the rest of your health story.
Your top 3 ranked health hypotheses are included in full with Mutant Free.
No new DNA test required. No credit card required.
Your complete raw DNA stays in your browser.
Mutant provides educational and informational genetic analysis. Mutant findings are health hypotheses, not diagnoses, and are not a substitute for medical evaluation, laboratory testing, clinical genetic testing, genetic counseling, medication management, or treatment. Potentially significant inherited findings may require confirmation through an appropriate clinical laboratory.